British Pharmacopoeia 2026

Helping you to access quality and compliance, quickly, easily and with confidence.

New, legally enforced standards available from 1 August 2025. The BP 2026 edition supersedes the BP 2025 and becomes legally effective on 1 January 2026 with all European Pharmacopoeia texts included.

Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.

It includes approximately 4,000 monographs, which are legally enforced by the Human Medicines Regulations 2012. Medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.

All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and internationally.

New for the BP 2026

The BP 2026 supersedes the BP 2025 and becomes legally effective on 1 January 2026. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.

Single-user licences and packages

Visit the BP website to purchase and view single-user licence package options.

*Single-user licences are granted solely to one designated holder.

Multi-user licences

If online access for more than one online user is required, organisations can enjoy cost-effective simultaneous access to the full text of the BP 2024 edition, on workstations, laptops and other portable devices.

Online customers can select from additional add-on options such as:

  • BP Archive - to get access to all BP editions from 2014 to date
  • British Approved Names (BAN) 2023 - giving access to this reference source of medicinal substance names